In a recent study, we observed that the detection of CK-19 and mammaglobin transcripts in bone marrow samples from untreated patients with breast cancer was superior to immunocytochemistry in predicting patients’ prognosis (Benoy et al, 2006a, 2006b). This evidence concerns the gene KRT19 and breast cancer.